Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 2
1949 6
1950 1
1951 1
1952 1
1953 1
1955 1
1957 3
1958 4
1959 10
1960 5
1961 1
1962 6
1963 8
1964 11
1965 9
1966 2
1970 2
1971 3
1972 4
1973 3
1974 17
1975 6
1976 11
1977 11
1978 10
1979 31
1980 18
1981 42
1982 45
1983 49
1984 58
1985 83
1986 94
1987 99
1988 118
1989 134
1990 115
1991 152
1992 192
1993 214
1994 268
1995 285
1996 378
1997 445
1998 419
1999 462
2000 589
2001 710
2002 865
2003 1059
2004 1385
2005 1789
2006 2186
2007 2434
2008 2950
2009 3526
2010 4130
2011 5056
2012 5935
2013 7091
2014 8427
2015 9759
2016 10158
2017 11175
2018 12875
2019 15333
2020 18373
2021 21208
2022 25457
2023 6972
Text availability
Article attribute
Article type
Publication date

Search Results

163,227 results
Results by year
Filters applied: . Clear all
Page 1
Aptamer-Based Targeted Protein Degradation.
Liu Y, Qian X, Ran C, Li L, Fu T, Su D, Xie S, Tan W. Liu Y, et al. ACS Nano. 2023 Mar 21. doi: 10.1021/acsnano.2c10379. Online ahead of print. ACS Nano. 2023. PMID: 36942868 Review.
The multifaceted roles of mitochondria.
Pucadyil TJ, Chipuk JE, Liu Y, O'Neill L, Chen Q. Pucadyil TJ, et al. Among authors: liu y. Mol Cell. 2023 Mar 16;83(6):819-823. doi: 10.1016/j.molcel.2023.02.030. Mol Cell. 2023. PMID: 36931251
Progression in immunotherapy for advanced prostate cancer.
Liang H, Liu Y, Guo J, Dou M, Zhang X, Hu L, Chen J. Liang H, et al. Among authors: liu y. Front Oncol. 2023 Feb 28;13:1126752. doi: 10.3389/fonc.2023.1126752. eCollection 2023. Front Oncol. 2023. PMID: 36925917 Free PMC article. Review.
Spatial epigenome-transcriptome co-profiling of mammalian tissues.
Zhang D, Deng Y, Kukanja P, Agirre E, Bartosovic M, Dong M, Ma C, Ma S, Su G, Bao S, Liu Y, Xiao Y, Rosoklija GB, Dwork AJ, Mann JJ, Leong KW, Boldrini M, Wang L, Haeussler M, Raphael BJ, Kluger Y, Castelo-Branco G, Fan R. Zhang D, et al. Among authors: liu y. Nature. 2023 Mar 15. doi: 10.1038/s41586-023-05795-1. Online ahead of print. Nature. 2023. PMID: 36922587
Research progress on non-protein-targeted drugs for cancer therapy.
Zhang Y, Lu L, Song F, Zou X, Liu Y, Zheng X, Qian J, Gu C, Huang P, Yang Y. Zhang Y, et al. Among authors: liu y. J Exp Clin Cancer Res. 2023 Mar 14;42(1):62. doi: 10.1186/s13046-023-02635-y. J Exp Clin Cancer Res. 2023. PMID: 36918935 Free PMC article. Review.
Advances in developing ACE2 derivatives against SARS-CoV-2.
Zhang H, Lv P, Jiang J, Liu Y, Yan R, Shu S, Hu B, Xiao H, Cai K, Yuan S, Li Y. Zhang H, et al. Among authors: liu y. Lancet Microbe. 2023 Mar 16:S2666-5247(23)00011-3. doi: 10.1016/S2666-5247(23)00011-3. Online ahead of print. Lancet Microbe. 2023. PMID: 36934742 Free PMC article. Review.
163,227 results
You have reached the last available page of results. Please see the User Guide for more information.